论文部分内容阅读
溴隐亭治疗分泌催乳素(prolactin,PRL)的垂体瘤早已有证明,以后发现溴隐亭还可使肿瘤缩小。近年来证明溴隐亭对分泌生长激素(growth hormone,GH)的垂体瘤也有类似效果。但溴隐亭口服麻烦且有副作用,剂量视病人试服后的耐受性而定。最近生产了一种注射用长效溴隐亭,深部注射后在4～6周内缓慢释放活性化合物。1次注射50mg 可抑制正常人PRL 分泌4～6周。
Bromocriptine treatment prolactin (prolactin, PRL) pituitary tumor has long been proven, and later found that bromocriptine can also make the tumor shrink. Bromocriptine has been shown to have similar effects on pituitary tumors that secrete growth hormone (GH) in recent years. However, bromocriptine is troublesome and has side effects. The dose depends on the tolerance of the patient after the test. A long-acting bromocriptine for injection has recently been produced that slowly releases the active compound within 4 to 6 weeks after deep injection. 1 injection of 50mg can inhibit the normal PRL secretion of 4 to 6 weeks.